Isotechnika Pharma Inc. (ISA.TO)
-Toronto | Prev Close: | 0.04 |
|---|
| Open: | 0.04 |
|---|
| Bid: | 0.04 |
|---|
| Ask: | 0.05 |
|---|
| 1y Target Est: | 1.50 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.04 - 0.04 |
|---|
| 52wk Range: | 0.03 - 0.13 |
|---|
| Volume: | 107,500 |
|---|
| Avg Vol (3m): | 108,402 |
|---|
| Market Cap: | 7.71M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 18.59 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Isotechnika Pharma Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of immunomodulating therapeutics. The companys lead drug, Voclosporin, is a calcineurin inhibitor that has completed Phase IIa...
View More 
0.52%